Your browser doesn't support javascript.
loading
Misuse of "study drugs:" prevalence, consequences, and implications for policy.
Sussman, Steve; Pentz, Mary Ann; Spruijt-Metz, Donna; Miller, Toby.
Afiliação
  • Sussman S; Preventive Medicine and Psychology, Institute for Health Promotion and Disease Prevention Research, University of Southern California, 1000 South Fremont, Unit #8, Alhambra, CA 91803, USA. ssussma@usc.edu
Subst Abuse Treat Prev Policy ; 1: 15, 2006 Jun 09.
Article em En | MEDLINE | ID: mdl-16764722
BACKGROUND: Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. RESULTS: Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education. CONCLUSION: Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Medicamentos sob Prescrição / Política de Saúde / Anfetaminas / Estimulantes do Sistema Nervoso Central / Metilfenidato Tipo de estudo: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2006 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Medicamentos sob Prescrição / Política de Saúde / Anfetaminas / Estimulantes do Sistema Nervoso Central / Metilfenidato Tipo de estudo: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2006 Tipo de documento: Article